MedPath
FDA Approval

Metaxalone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 18, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metaxalone(800 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Quality Care Products, LLC

Quality Care Products, LLC

831276758

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

NDC Product Code
55700-911
Application Number
ANDA203695
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 18, 2022
Code: 1NMA9J598YClass: ACTIBQuantity: 800 mg in 1 1
ALGINIC ACIDInactive
Code: 8C3Z4148WZClass: IACT
AMMONIUM ALGINATEInactive
Code: Q9QKJ39Q3XClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
CALCIUM ALGINATEInactive
Code: 8P20S56HZIClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath